Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α.
Keane FM, Nadvi NA, Yao TW, Gorrell MD. Keane FM, et al. Among authors: nadvi na. FEBS J. 2011 Apr;278(8):1316-32. doi: 10.1111/j.1742-4658.2011.08051.x. Epub 2011 Mar 9. FEBS J. 2011. PMID: 21314817 Free article.
A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation.
Osborne B, Yao TW, Wang XM, Chen Y, Kotan LD, Nadvi NA, Herdem M, McCaughan GW, Allen JD, Yu DM, Topaloglu AK, Gorrell MD. Osborne B, et al. Among authors: nadvi na. Biochim Biophys Acta. 2014 Jul;1844(7):1248-59. doi: 10.1016/j.bbapap.2014.03.015. Epub 2014 Apr 6. Biochim Biophys Acta. 2014. PMID: 24717288
Fibroblast activation protein and chronic liver disease.
Wang XM, Yao TW, Nadvi NA, Osborne B, McCaughan GW, Gorrell MD. Wang XM, et al. Among authors: nadvi na. Front Biosci. 2008 Jan 1;13:3168-80. doi: 10.2741/2918. Front Biosci. 2008. PMID: 17981786 Review.
The dipeptidyl peptidase IV family in cancer and cell biology.
Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, McCaughan GW, Gorrell MD. Yu DM, et al. Among authors: nadvi na. FEBS J. 2010 Mar;277(5):1126-44. doi: 10.1111/j.1742-4658.2009.07526.x. Epub 2010 Jan 13. FEBS J. 2010. PMID: 20074209 Free article. Review.
Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I.
Akladios FN, Nadvi NA, Park J, Hanrahan JR, Kapoor V, Gorrell MD, Church WB. Akladios FN, et al. Among authors: nadvi na. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1579-81. doi: 10.1016/j.bmcl.2011.12.138. Epub 2012 Jan 10. Bioorg Med Chem Lett. 2012. PMID: 22281190
Homology modeling of human kynurenine aminotransferase III and observations on inhibitor binding using molecular docking.
Nematollahi A, Church WB, Nadvi NA, Gorrell MD, Sun G. Nematollahi A, et al. Among authors: nadvi na. Cent Nerv Syst Agents Med Chem. 2014;14(1):2-9. doi: 10.2174/1871524914666140416095523. Cent Nerv Syst Agents Med Chem. 2014. PMID: 24739074
Expression, purification and crystallization of human kynurenine aminotransferase 2 exploiting a highly optimized codon set.
Sun G, Nematollahi A, Nadvi NA, Kwan AH, Jeffries CM, Church WB. Sun G, et al. Among authors: nadvi na. Protein Expr Purif. 2016 May;121:41-5. doi: 10.1016/j.pep.2016.01.004. Epub 2016 Jan 8. Protein Expr Purif. 2016. PMID: 26773745
Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia.
Jayawickrama GS, Sadig RR, Sun G, Nematollahi A, Nadvi NA, Hanrahan JR, Gorrell MD, Church WB. Jayawickrama GS, et al. Among authors: nadvi na. Curr Med Chem. 2015;22(24):2902-18. doi: 10.2174/0929867322666150608094054. Curr Med Chem. 2015. PMID: 26051411 Review.
High resolution crystal structures of human kynurenine aminotransferase-I bound to PLP cofactor, and in complex with aminooxyacetate.
Nadvi NA, Salam NK, Park J, Akladios FN, Kapoor V, Collyer CA, Gorrell MD, Church WB. Nadvi NA, et al. Protein Sci. 2017 Apr;26(4):727-736. doi: 10.1002/pro.3119. Epub 2017 Mar 6. Protein Sci. 2017. PMID: 28097769 Free PMC article.
Clinically Linked Mutations in the Central Domains of Cardiac Myosin-Binding Protein C with Distinct Phenotypes Show Differential Structural Effects.
Nadvi NA, Michie KA, Kwan AH, Guss JM, Trewhella J. Nadvi NA, et al. Structure. 2016 Jan 5;24(1):105-115. doi: 10.1016/j.str.2015.11.001. Epub 2015 Dec 10. Structure. 2016. PMID: 26688216 Free article.